NCT06133764

Brief Summary

Background The odontogenic keratocysts (OKCs) have been one of the maxillofacial region's most contentious pathological phenomena. Decompression/marsupialization (D/M), enucleation (E), enucleation + chemical cauterization with Carnoy's solution (E+CS), enucleation + peripheral ostectomy (E + PO), as opposed to enucleation + chemical cauterization with Carnoy's solution + peripheral ostectomy (E + CS + PO), were used during surgery to ensure that no epithelial remnants were left behind. Rationale Through the management of OKC a recurrence could occur, the effectiveness of Decompression/marsupialization (D/M), Enucleation (E), Enucleation+Carnoy's solution chemical cauterization (E+CS), Enucleation+peripheral ostectomy (E+PO), Enucleation+Carnoy's solution chemical cauterization + peripheral ostectomy (E+CS + PO), will be analyzed

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 24, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

November 8, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 15, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 7, 2026

Status Verified

December 1, 2025

Enrollment Period

1.3 years

First QC Date

November 8, 2023

Last Update Submit

January 4, 2026

Conditions

Keywords

Odontogenic cystsOdontogenic Keratocysts

Outcome Measures

Primary Outcomes (4)

  • Healing period

    The bone filling will monitored by using computed tomography scans

    Starting from the postoperative third month up to the postoperative ninth month

  • Measurement of the bony cavity

    A presence of radiolucent area in the computed tomography scans

    At the end of the postoperative ninth month

  • Recurrence rate

    The new occurrence of the previously removed odontogenic keratocyst will be documented

    At the end of the postoperative fifth year

  • Recurrence rate

    The new occurrence of the previously removed odontogenic keratocyst will be documented

    At the end of the postoperative tenth year

Study Arms (5)

Enucleation + Peripheral ostectomy + Carnoy's solution chemical cauterization (E+ PO+ CS)

EXPERIMENTAL

The odontogenic keratocysts will be treated using enucleation, followed by peripheral ostectomy and then Carnoy's solution

Procedure: Enucleation+ Peripheral Ostectomy+Carnoy's solution chemical cauterization (E+CS + PO)

Decompression/marsupialization (D/M)

EXPERIMENTAL

The odontogenic keratocysts will be managed by either Decompression or marsupialization

Procedure: Decompression/ marsupialization (D/M)

Enucleation (E)

EXPERIMENTAL

The odontogenic keratocysts will only be managed by Enucleation (E)

Procedure: Enucleation (E)

Enucleation+Carnoy's solution (E+CS)

EXPERIMENTAL

odontogenic keratocysts will be managed by Enucleation, followed by Carnoy's solution

Procedure: Enucleation+Carnoy's solution (E+CS)

Enucleation+ Peripheral Ostectomy (E+PO)

EXPERIMENTAL

The odontogenic keratocysts will be treated using Enucleation, followed by peripheral ostectomy (E+PO)

Procedure: Enucleation+ Peripheral Ostectomy (E+ PO)

Interventions

The enucleation procedures, which were meticulously carried out in order to remove the odontogenic keratocyst in one piece without breaking its lining or leaving any epithelial remnants.The peripheral ostectomy treatment will be carried out with a large spherical bur and plenty of irrigation.After filling the bone cavity with more sterile gauze, the Carnoy's solution was slowly injected into it with a plastic syringe. The gauze was continuously injected with CS until it was fully saturated without leaking too much into the surrounding tissues. The CS was held in place for 3 minutes.

Also known as: (E + PO+ CS)
Enucleation + Peripheral ostectomy + Carnoy's solution chemical cauterization (E+ PO+ CS)

A surgical window will be created in the cyst wall to drain the contents while retaining continuity between the cyst and the oral cavity

Also known as: D/M
Decompression/marsupialization (D/M)

The enucleation will be accomplished in the same manner that it will be performed in the group of Enucleation+ Peripheral Ostectomy+Carnoy's solution chemical cauterization (E+ PO+ CS).

Also known as: E
Enucleation (E)

Both enucleation and Carnoy's solution will be carried out as planned in the group Enucleation+ Peripheral Ostectomy+Carnoy's solution chemical cauterization (E+ PO+ CS).

Also known as: (E+CS)
Enucleation+Carnoy's solution (E+CS)

Both enucleation and peripheral ostectomy will be carried out as planned in the group Enucleation+ Peripheral Ostectomy+ Carnoy's solution chemical cauterization (E+ PO+ CS).

Also known as: (E+PO)
Enucleation+ Peripheral Ostectomy (E+PO)

Eligibility Criteria

Age10 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All odontogenic keratocysts that are treated by the following surgical treatment modalities:
  • Enucleation followed by peripheral ostectomy and Carnoy's solution
  • Decompression/ marsupialization
  • Enucleation
  • Enucleation and Carnoy's solution
  • Enucleation and Peripheral Ostectomy
  • Follow-up period 10 years

You may not qualify if:

  • Cases treated with resection
  • Cases showed neoplastic transformation in their pathology
  • Cyst Like lesions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

College of Dentistry, Qassim University

Buraidah, Al-Qassim Region, 1162, Saudi Arabia

Location

MeSH Terms

Conditions

Odontogenic Cysts

Interventions

DecompressionEudragit E PO

Condition Hierarchy (Ancestors)

Jaw CystsBone CystsCystsNeoplasmsJaw DiseasesMusculoskeletal DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsPressureMechanical PhenomenaPhysical Phenomena

Study Officials

  • Ghada A Khalifa, Professor

    College of Dentistry, Qassim University, Saudi Arabia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The patients, investigators, and outcomes assessor will not be informed about the study
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The patents will be divided into five groups according to the treatment modalities used to treat their odontogenic cysts
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Maxillofacial Surgery and Diagnostic Science

Study Record Dates

First Submitted

November 8, 2023

First Posted

November 15, 2023

Study Start

February 24, 2023

Primary Completion

June 30, 2024

Study Completion

December 31, 2024

Last Updated

January 7, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

All data will be available on request by contact the principle investigator

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
12 months after publication
Access Criteria
Contact the principle investigator via email: g.khalifa@qu.edu.sa

Locations